Replies to post #14711 on Protagenic Therapeutics Inc. (PTIX)

[StockBang]

If you look at the 10q, most of that loss was from kazaa, which is no longer around. It may be for Q4 2011, but not after.

[QTRADERQ]

Turnarounds are valued on multiples of revenues, not eps

The reason for this is because Wall Street discounts in future expectations (ie eps, sale of Kazaa, etc.) The ramp up in revenues will precede the future earnings. If Wall Street was to wait for the eps to be actually reported, they would miss the turnaround by at least 3 mos - 6 mos. In 2013, when ATRN has completed their turnaround and the bottom line shows the earnings, then they will be valued on multiples of earnings... but not today.